Cardiovascular complications in patients hospitalized with COVID-۱۹: A cross-sectional study

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 12

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JNACS-1-2_003

تاریخ نمایه سازی: 30 مرداد 1403

Abstract:

This study aimed to evaluate the cardiovascular complications in patients hospitalized with COVID-۱۹. An analytical cross-sectional study was conducted to investigate the prevalence of cardiovascular disorders among patients infected with Severe Acute Respiratory Syndrome Coronavirus ۲ (SARS-CoV-۲). The study focused on individuals admitted to Shahid Beheshti Hospital in Kashan throughout ۲۰۱۸-۲۰۱۹. A comprehensive questionnaire was administered to collect demographic information, vital signs upon admission, symptoms experienced, underlying medical conditions, cardiovascular risk factors, duration of hospitalization, discharge status, and laboratory test results. The data encompassed a wide range of variables including age, sex, race, vital signs, symptoms, comorbidities, cardiovascular risk factors, hospitalization duration, discharge outcome, and laboratory parameters. The study encompassed a total of ۴۴۰ patients diagnosed with COVID-۱۹. The average age of the participants was ۶۱.۲۸ (SD=۱۸.۹۷) years. The presence of a cardiac disorder exhibits a statistically significant correlation with admission to the intensive care unit (ICU) (P=۰.۰۰۴). Furthermore, the findings indicate that gender, age, decreased level of consciousness, pulse rate (PR), respiratory rate (RR), oxygen saturation (SPO۲), and various laboratory parameters (excluding white blood cell (WBC), erythrocyte sedimentation rate (ESR), Mg, Troponin, pH, PaO۲, and PaCO۲), alongside ICU hospitalization and mechanical ventilation, significantly associated with patient mortality (P<۰.۰۵). SARS-CoV-۲ has the potential to exacerbate conditions in individuals with pre-existing cardiovascular diseases, necessitating meticulous planning of treatment strategies. Additionally, SARS-CoV-۲ can induce cardiovascular disorders in affected individuals, underscoring the importance of vigilant monitoring and management of resultant cardiac complications during the treatment of SARS-CoV-۲.

Authors

Amir

Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Golestan University of Medical Sciences, Gorgan, Iran

Mohsen

Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Trauma Nursing Research Center, Kashan University of Medical Sciences and Health Services, Kashan, Iran

Fatemeh

Sina Hospital, Tabriz University of Medical Science, Tabriz, Iran

Fatemeh Sadat

Social Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences and Health Services, Kashan, Iran

Fariba

Department of Cardiology, School of Medicine, Shahid Beheshti Hospital, Kashan University of Medical Sciences and Health Services, Kashan, Iran

Mojtaba

Department of Community Medicine, School of Medicine, Trauma Research Center, Kashan University of Medical Sciences and Health Services, Kashan, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Zhang R, Wang X, Ni L, Di X, Ma B, ...
  • Hageman JR. The coronavirus disease ۲۰۱۹ (COVID-۱۹). Pediatr Ann. ۲۰۲۰;۴۹(۳):۱-۲ ...
  • Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, ...
  • Raman R, Patel KJ, Ranjan K. COVID-۱۹: Unmasking Emerging SARS-CoV-۲ ...
  • Frisoni P, Neri M, D'Errico S, Alfieri L, Bonuccelli D, ...
  • Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - ...
  • Chen G, Li X, Gong Z, Xia H, Wang Y, ...
  • Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, ...
  • Cappuccio FP, Siani A. Covid-۱۹ and cardiovascular risk: Susceptibility to ...
  • Wang D, Hu B, Hu C, Zhu F, Liu X, ...
  • Shahjouei S, Naderi S, Li J, Khan A, Chaudhary D, ...
  • Schvartz A, Belot A, Kone-Paut I. Pediatric Inflammatory Multisystem Syndrome ...
  • Yang J, Zheng Y, Gou X, Pu K, Chen Z, ...
  • Kochi AN, Tagliari AP, Forleo GB, Fassini GM, Tondo C. ...
  • Zhou F, Yu T, Du R, Fan G, Liu Y, ...
  • Imazio M, Klingel K, Kindermann I, Brucato A, De Rosa ...
  • Gough PJ, Gomez IG, Wille PT, Raines EW. Macrophage expression ...
  • نمایش کامل مراجع